Paul A. Robertson, MD; Helen J. Ross, MD; Robert A. Figlin, MD
William B. Coley, MD, a surgeon of the early 20th century, noted the regression of a soft-tissue sarcoma in the neck of a patient after a life-threatening bacterial infection. He subsequently developed Coley toxins (sterilized cultures of various gram-negative bacilli), which he administered to patients with solid tumors to reproduce the antitumor effect he had observed with severe bacterial infections. The search for a pathophysiologic explanation of this phenomenon led Carswell and colleagues (1) in 1974 to describe tumor necrosis factor. This endotoxin-induced serum factor caused necrosis within 24 hours of subcutaneously transplanted methylcholanthrene A-induced sarcoma in BCG-primed mice. The
Learn more about subscription options.
Register Now for a free account.
Robertson PA, Ross HJ, Figlin RA. Tumor Necrosis Factor Induces Hemorrhagic Necrosis of a Sarcoma. Ann Intern Med. 1989;111:682–684. doi: 10.7326/0003-4819-111-8-682
Download citation file:
Published: Ann Intern Med. 1989;111(8):682-684.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only